Researchers at Remington-Davis Clinical Research in Columbus are looking for adults with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) to take part in a clinical research study. This study is evaluating an investigational nebulized suspension medication as a potential treatment for COPD.
COPD is a group of lung diseases, including emphysema and chronic bronchitis.
You May Qualify if You:
Your health will be monitored carefully by the study team throughout the study. All study-related medications and assessments will be provided at no cost to you.
Compensation up to $550 for time and travel may be provided.
Complete the form today to get in touch with Remington-Davis Clinical Research.